longbridgelongbridge
  • Products
  • Fees
  • Download
  • Promotions
    Welcome RewardsReferral ProgramUS Pre-Market Options Trading
  • For Institutions
    Corporate ServicesDevelopers
  • Help
  • About
    About LongbridgeLicense & RegulatoryMedia CoverageJoin Us
longbridge
  • Home
  • Discover
    Discover
    Global MarketsStock ScreenerFinancial Calendar
  • News & Info
    News & Info
    NewsInsightsLiveAcademy
  • Watchlist
  • Trade
  • Notification
  • LongbridgeAI
Home
Discover
News & Info
Watchlist
Trade
LongbridgeAI
Quote ListQuote List

Taikang CNI Public Health and Medical Health ETF(159760.SZ)

Last Updated 00:00:00
longbridge loading
News
Holdings
Overview
Company Encyclopedia
View More
name
Taikang CNI Public Health and Medical Health ETF
159760.SZ
News
View More

New Progress in Centralized Procurement of Chinese Herbal Pieces: 41 Varieties Included, 300 Billion Market Landscape to Change

Wallstreetcn·04/14/2026 20:17
HK
01666
-1.07%
HK
00570
-0.61%
HK
03613
-1.51%
Wallstreetcn·04/14/2026 20:17
HK
01666
-1.07%
HK
00570
-0.61%
HK
03613
-1.51%

Taikang CNI Public Health and Medical Health ETF rose over 1% during trading, showcasing domestic innovative achievements at an international event, and the CXO sector is experiencing a comprehensive recovery

腾讯新闻 - 财经·04/02/2026 14:34
SH
688336
-1.44%
SZ
160219
-0.38%
SZ
159760
-0.36%
腾讯新闻 - 财经·04/02/2026 14:34
SH
688336
-1.44%
SZ
160219
-0.38%
SZ
159760
-0.36%
© 2026 Longbridge|Disclaimer

Event Tracking

May19
HKEX Discloses: JPMorgan Increases Short Position in Wuxi AppTec H-Share to 3.34% on May 14
10:07
May18
Schroders PLC Increased Holdings in Hengrui Medicine by 663,000 Shares on May 12 at Cost of Approx. 45.55 Million HKD
11:57
BlackRock Increases Stake in Wuxi AppTec H-Shares to 6.32%
09:25
May15
Bristol Myers Squibb and Hengrui Medicine Reach Billions-Deal to Co-Develop Drugs and Conduct Early Clinical Trials in China
15:44
Orient Securities: WuXi AppTec 2026 Q1 Net Profit 4.65B, Maintains Buy Rating with Target Price 140.16 Yuan
07:23
Hengrui Medicine and BMS Reach $15.2 Billion Super BD Deal
02:11